Unknown

Dataset Information

0

Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation.


ABSTRACT: Bone marrow-derived mesenchymal stromal cells (BM-MSCs) are multipotent progenitor cells that have shown promise for several different therapeutic applications. As they are able to modulate the function of several types of immune cells, BM-MSCs are highly important in the field of cell-based immunotherapy. Understanding BM-MSC-natural killer (NK) cell interactions is crucial for improving their therapeutic efficiency. Here, we observed that the type of NK cell-activating cytokine (e.g., IL-2, IL-12, IL-15 and IL-21) strongly influenced the outcomes of their interactions with BM-MSCs. The expression patterns of the ligands (CD112, CD155, ULPB-3) and receptors (LAIR, NCR) mediating the cross-talk between BM-MSCs and NK cells were critically modulated following co-culture. BM-MSCs partially impaired NK cell proliferation but up-regulated their secretion of IFN-? and TNF-?. As they are cytotoxic, activated NK cells induced the killing of BM-MSCs. Indeed, BM-MSCs triggered the degranulation of NK cells and increased their release of perforin and granzymes. Interestingly, activated NK cells induced ROS generation within BM-MSCs that caused their decreased viability and reduced expression of serpin B9. Collectively, our observations reveal that BM-MSC-NK cell interactions may impact the immunobiology of both cell types. The therapeutic potential of BM-MSCs will be significantly improved once these issues are well characterized.

SUBMITTER: Najar M 

PROVIDER: S-EPMC6235772 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation.

Najar Mehdi M   Fayyad-Kazan Mohammad M   Meuleman Nathalie N   Bron Dominique D   Fayyad-Kazan Hussein H   Lagneaux Laurence L  

Journal of cell communication and signaling 20180119 4


Bone marrow-derived mesenchymal stromal cells (BM-MSCs) are multipotent progenitor cells that have shown promise for several different therapeutic applications. As they are able to modulate the function of several types of immune cells, BM-MSCs are highly important in the field of cell-based immunotherapy. Understanding BM-MSC-natural killer (NK) cell interactions is crucial for improving their therapeutic efficiency. Here, we observed that the type of NK cell-activating cytokine (e.g., IL-2, IL  ...[more]

Similar Datasets

| S-EPMC7450165 | biostudies-literature
| S-EPMC4857408 | biostudies-literature
| S-EPMC8751335 | biostudies-literature
| S-EPMC5852762 | biostudies-literature
| S-EPMC6290099 | biostudies-literature
| S-EPMC6591688 | biostudies-literature
| S-EPMC4443932 | biostudies-literature
| S-EPMC5005173 | biostudies-literature
| S-EPMC4275011 | biostudies-literature
| S-EPMC5405000 | biostudies-literature